Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward Keystone

Showing results (61-70 of 86) with videos related to

Pageof 9
Sort By:
ACR Open Rheumatology|November 29, 2019
Association of Arthritis Onset with Influenza: Analysis of the Canadian Early Inflammatory Arthritis CohortFatima Kudaeva, Mark Speechley, Neil Klar, et al.
Arthritis and Rheumatism|December 1, 2007
Safety and efficacy of additional courses of rituximab in patients with active rheumatoid arthritis: an open-label extension analysisEdward Keystone, Roy Fleischmann, Paul Emery, et al.
Rheumatology (Oxford, England)|July 11, 2013
The effect of golimumab on haemoglobin levels in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitisDaniel E Furst, Jonathan Kay, Mary Chester Wasko, et al.
The Journal of Rheumatology|February 13, 2002
CD4 coating, but not CD4 depletion, is a predictor of efficacy with primatized monoclonal anti-CD4 treatment of active rheumatoid arthritisUrsula Mason, Jose Aldrich, Ferdinand Breedveld, et al.
Arthritis and Rheumatism|March 2, 2006
Infliximab treatment maintains employability in patients with early rheumatoid arthritisJosef S Smolen, Chenglong Han, Désirée van der Heijde, et al.
The New England Journal of Medicine|June 13, 2013
Therapies for active rheumatoid arthritis after methotrexate failureJames R O'Dell, Ted R Mikuls, Thomas H Taylor, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|May 1, 2024
Having More Tender Than Swollen Joints Is Associated With Worse Patient-Reported Outcomes in Patients With Early RACharis F Meng, Yvonne C Lee, Orit Schieir, et al.
Clinical and Experimental Rheumatology|December 21, 2019
Tofacitinib in combination with methotrexate in patients with rheumatoid arthritis: patient-reported outcomes from the 24-month Phase 3 ORAL Scan studyVibeke Strand, Désirée van der Heijde, Yoshiya Tanaka, et al.
Arthritis and Rheumatism|November 6, 2004
Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trialE William St Clair, Désirée M F M van der Heijde, Josef S Smolen, et al.
Arthritis and Rheumatism|March 2, 2006
Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab: results from the ASPIRE trialJosef S Smolen, Désirée M F M Van Der Heijde, E William St Clair, et al.
Pageof 9

Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
ACR Open Rheumatology|November 29, 2019
Association of Arthritis Onset with Influenza: Analysis of the Canadian Early Inflammatory Arthritis CohortFatima Kudaeva, Mark Speechley, Neil Klar, et al.
Arthritis and Rheumatism|December 1, 2007
Safety and efficacy of additional courses of rituximab in patients with active rheumatoid arthritis: an open-label extension analysisEdward Keystone, Roy Fleischmann, Paul Emery, et al.
Rheumatology (Oxford, England)|July 11, 2013
The effect of golimumab on haemoglobin levels in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitisDaniel E Furst, Jonathan Kay, Mary Chester Wasko, et al.
The Journal of Rheumatology|February 13, 2002
CD4 coating, but not CD4 depletion, is a predictor of efficacy with primatized monoclonal anti-CD4 treatment of active rheumatoid arthritisUrsula Mason, Jose Aldrich, Ferdinand Breedveld, et al.
Arthritis and Rheumatism|March 2, 2006
Infliximab treatment maintains employability in patients with early rheumatoid arthritisJosef S Smolen, Chenglong Han, Désirée van der Heijde, et al.
The New England Journal of Medicine|June 13, 2013
Therapies for active rheumatoid arthritis after methotrexate failureJames R O'Dell, Ted R Mikuls, Thomas H Taylor, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|May 1, 2024
Having More Tender Than Swollen Joints Is Associated With Worse Patient-Reported Outcomes in Patients With Early RACharis F Meng, Yvonne C Lee, Orit Schieir, et al.
Clinical and Experimental Rheumatology|December 21, 2019
Tofacitinib in combination with methotrexate in patients with rheumatoid arthritis: patient-reported outcomes from the 24-month Phase 3 ORAL Scan studyVibeke Strand, Désirée van der Heijde, Yoshiya Tanaka, et al.
Arthritis and Rheumatism|November 6, 2004
Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trialE William St Clair, Désirée M F M van der Heijde, Josef S Smolen, et al.
Arthritis and Rheumatism|March 2, 2006
Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab: results from the ASPIRE trialJosef S Smolen, Désirée M F M Van Der Heijde, E William St Clair, et al.
Pageof 9